We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
67 hedge funds and large institutions have $29.7M invested in CTI BioPharma Corp. (DE) Common Stock in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
16% more capital invested
Capital invested by funds: $25.6M → $29.7M (+$4.03M)
11% less funds holding
Funds holding: 75 → 67 (-8)
13% less call options, than puts
Call options by funds: $88K | Put options by funds: $101K
40% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 20
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
67
Holders Change
-8
Holders Change %
-10.67%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
12
Reduced
20
Closed
14
Calls
$88K
Puts
$101K
Net Calls
-$13K
Net Calls Change
-$47K
Top Buyers
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$210K |
| 2 |
Renaissance Technologies
New York
|
+$205K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$40.3K |
| 4 |
State Street
Boston,
Massachusetts
|
+$37.9K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$27.7K |
